UGT1A1 and Decreased liver function: We suggest conducting a genetic analysis of UGT1A1 for patients experiencing chemotherapy-induced hyperbilirubinemia without any signs of liver dysfunction to avoid unnecessary changes in chemotherapy that could increase the risk of relapse.